NEW YORK, Aug. 7, 2015 /PRNewswire/ -- Morgan & Morgan announces that it is investigating potential claims against the board of directors of Merge Healthcare Incorporated ("Merge Healthcare" or the "Company") (MRGE) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to IBM in a transaction valued at approximately $1 billion.
If you own shares of Merge Healthcare and would like to learn more about the Merge Healthcare shareholder investigation, you may contact Morgan & Morgan at 1(800) 732-5200 or email firstname.lastname@example.org.
Under the terms of the transaction, Merge shareholders will receive $7.13 in cash for each share of Merge they own. The investigation relates to whether the proposal is fair to the public shareholders and if the Company's Board of Directors breached their fiduciary duties to shareholders.
About Morgan & Morgan
Morgan & Morgan is one of the nation's largest 200 law firms. In addition to shareholder rights, the firm also practices in the areas of antitrust, personal injury, consumer protection, overtime, and product liability. All of the Firm's legal endeavors are rooted in its core mission: provide investor and consumer protection and always fight "for the people."
Attorney advertising. Prior results do not guarantee a similar outcome.
Morgan & Morgan
Peter Safirstein, Esq.
28 West 44th Street
New York, NY 10036
SOURCE Morgan & Morgan